Pediatric pars planitis: a review

S Khochtali, P Ozdal, AF AlBloushi, W Nabi… - Ocular Immunology …, 2023 - Taylor & Francis
Purpose To provide an overview of pediatric pars planitis. Methods Narrative literature
review. Results Pars planitis refers to the idiopathic subset of intermediate uveitis in which …

Diagnosis and Management of Non-Infectious Uveitis in Pediatric Patients

AT Nguyen, I Koné-Paut, P Dusser - Pediatric Drugs, 2024 - Springer
Uveitis in children accounts for 5–10% of all cases. The causes vary considerably.
Classically, uveitis is distinguished according to its infectious or inflammatory origin and …

Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders

J Sota, S Guerriero, G Lopalco, A Tufan… - Ocular immunology …, 2024 - Taylor & Francis
Purpose The clinical relevance of human leukocyte antigen (HLA) subtypes such as HLA-
B51 on Behçet's disease (BD)-related uveitis and non-infectious uveitis (NIU) unrelated to …

The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study

T Tao, S Yang, D He, X Peng, Z Wang, Q Jiang… - Ophthalmology and …, 2024 - Springer
Introduction This study aimed to assess the efficacy and safety of adalimumab in pediatric
patients with chronic non-infectious posterior uveitis and panuveitis (not associated with …

Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry

M Tarsia, A Vitale, C Gaggiano, J Sota… - Ophthalmology and …, 2024 - Springer
Introduction Since many biological drug patents have expired, biosimilar agents (BIOs) have
been developed; however, there are still some reservations in their use, especially in …

Efficacy of adalimumab in pediatric non-infectious uveitis with and without anterior segment inflammation

C Zhang, X Xue, J Xiao, Q Li, Y Zhai, Y Chen - BMC ophthalmology, 2025 - Springer
Background This study aimed to identify the clinical characteristics of cases that is related to
the response rate of adalimumab (ADA) treatment. Methods A retrospective review of …

[HTML][HTML] The Efficacy of Adalimumab Treatment in Pediatric Non-Infectious Uveitis: A Retrospective Cohort Study

KÖ Yalçınsoy, O Özen, YÖ Erol… - Turkish Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Objectives To evaluate the clinical features of pediatric non-infectious uveitis (NIU) patients
treated with adalimumab (ADA) and the efficacy of ADA in patients unresponsive to …

Vogt–Koyanagi–Harada Syndrome (VKHS): First Two Cases Reported in Pediatric Age Group in Oman

S Al Hashmi, N Al Habsi… - Case Reports in …, 2023 - Wiley Online Library
The Vogt–Koyanagi–Harada syndrome (VKHS) is a unique form of granulomatous
autoimmune disease that mostly impacts the pigmented tissues of the body. The main …

Screen high-risk paediatric patients for non-infectious uveitis and consider its treatment options

S Fung - Drugs & Therapy Perspectives, 2024 - Springer
Paediatric non-infectious uveitis can lead to vision loss and permanent damage to the eye. It
is difficult to diagnose, as it often presents asymptomatically, and can have a different …

Efficacy of Adalimumab in pediatric non-infectious uveitis with apparent and non-apparent anterior uveitis

C Zhang, X Xue, J Xiao, Q Li, Y Zhai, Y Chen - 2024 - researchsquare.com
Background Adalimumab (ADA) has been used for treating various types of pediatric non-
infectious uveitis. Existing studies lack an examination of the correlation between the clinical …